All Posts:liver cancer
-
Georgetown Study Highlights Opportunities for Liver Cancer Interventions in Thailand
Safer pesticide practices, clean drinking water, and effective community health programs could help reduce liver and bile duct cancer risk in Thailand, according to a new study by researchers at Georgetown’s Lombardi Comprehensive Cancer Center.
Category: News Release
-
New Drug Prevents Liver Damage, Obesity and Glucose Intolerance in Mice on High-Fat Diet
WASHINGTON (January 21, 2020) — Mice given a new drug targeting a key gene involved in lipid and glucose metabolism could tolerate a high-fat diet regimen (composed of 60% fat from lard) without developing significant liver damage, becoming obese, or disrupting their body’s glucose balance. The study by Georgetown Lombardi Comprehensive Cancer Center researchers appeared […]
Category: News Release
-
Georgetown Lombardi Clinical Trial Helps Advance Use of Immunotherapy in Liver Cancer
(January 4, 2020) — In August of 2016, Dan Hilton arrived at MedStar Georgetown University Hospital to be evaluated for a liver transplant. He had been diagnosed with cirrhosis, the result of a hepatitis C infection contracted many years earlier. After multiple tests, he received unexpected news; the doctors found tumors on his liver. They […]
Category: Lombardi Stories
-
Can Green Tea Prevent Liver Cancer?
Georgetown University basic science researcher and oncology professor Fung Lung Chung, PhD, and Associate Professor of Oncology Aiwu Ruth He, MD, PhD, are testing the power of an extract found in green tea to prevent cancer in cirrhotic livers.
Category: Lombardi Stories
-
Carnegie Renews Classification of Georgetown as ‘Very High Research University’
Georgetown has once again been classified by the Carnegie Classification of Institutions of Higher Education as an institution with “very high research activity.”
Category: Lombardi Stories
-
Liver Cancer Deaths Rise, Along with Hope for Better Treatments
Nationwide and locally in D.C., deaths from liver cancer have significantly risen over the past 16 years. Despite this grim news, Aiwu Ruth He, MD, PhD, an associate professor at Georgetown Lombardi Comprehensive Cancer Center, sees hope for meaningful progress in liver cancer diagnosis and treatment.
Category: Lombardi Stories